Answers are grounded in this paper and cite their sources.
Artesunate is a semisynthetic derivative of the natural product artemisinin, isolated from Artemisia annua and characterized by the biologically important endoperoxide bridge. Beyond its established use in malaria treatment, in recent decades, artesunate has attracted growing research interest as an anticancer agent. Despite encouraging preclinical results, clinical studies demonstrated only modest efficacy when artesunate was used as a single compound, due to its low bioavailability, toxicity, and unfavorable side effects. For this reason, artesunate derivatization has attracted significant attention, as the resulting derivatives often exhibit superior anticancer activity in both in vitro and in vivo studies compared with artesunate alone. This review offers a comprehensive overview of reported artesunate derivatives, structured into sections based on the type of molecule employed for derivatization and highlights the expanding research on their anticancer activity. Currently emerging strategies that include hybridization and nanocarrier-based delivery systems which may accelerate the clinical translation of artesunate derivatives and harness their potential in anticancer drug discovery are also discussed. While significant progress has been made, a lot of the research field still remains underexplored.
No takes yet. Share an insight, caveat, or question.
Selaković et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: